Back to CRL
MACKENZIE FINANCIAL CORP → CRL
MACKENZIE FINANCIAL CORP CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
7
Latest value
$30M
Q3 2026
Peak value
$157.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $155.7M |
| Q3 2025 | $1.6M |
| Q4 2025 | $157.5M |
| Q4 2025 | $1.1M |
| Q1 2026 | $102.6M |
| Q2 2026 | $351K |
| Q3 2026 | $30M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30M | 101.8K | — | — |
| Q2 2026 | $351K | 1.5K | — | — |
| Q1 2026 | $102.6M | 594.8K | — | — |
| Q4 2025 | $1.1M | 1.19M | — | — |
| Q4 2025 | $157.5M | 781.5K | — | — |
| Q3 2025 | $1.6M | 1.03M | — | — |
| Q3 2025 | $155.7M | 995.4K | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$362.1M
$334.6M
$328.4M
$323.2M